Gynecologic cancers in pregnancy: Guidelines of an international consensus meeting

Frédéric Amant, Kristel Van Calsteren, M. J. Halaska, J. Beijnen, L. Lagae, M. Hanssens, L. Heyns, L. Lannoo, P. Ottevanger, W. Van Den Bogaert, L. Ungár, I. Vergote, A. Du Bois

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cancer in pregnancy presents a rare coincidence which demands intensive interdisciplinary care. Among this, gynecologic cancer is a special challenge because cancer or treatment may not only affect the pregnant women in general but involve the reproductive tract and fetus directly. Currently, there are no guidelines on how to deal with this special coincidence. An international consensus meeting on staging and treatment of gynecologic malignancies during pregnancy including systematic literature search, interpretation, and preparation followed by a physical meeting of all participants with intensive discussion. In the absence of large trials and randomized studies, recommendations were based on available literature data and personal experience, thus representing a low but best achievable level of evidence. Randomized trials and prospective studies on cancer treatment during pregnancy are lacking. Gynecologic cancer during pregnancy is a demanding problem and multidisciplinary expertise should be available. Counseling both parents on the maternal prognosis and fetal risk is needed. When there is a firm desire to continue the pregnancy, gynecologic cancer can be treated in selected cases. The staging and treatment should follow the standard approach as much as possible. Guidelines for safe pelvic surgery during pregnancy are presented. Mainly in cervical and ovarian cancer, chemotherapy and an alternative surgical approach need to be considered. Administration of chemotherapy during the second or third trimester may probably not increase the incidence of congenital malformations. Until now, the long-term outcome of children in utero exposed to oncological treatment modalities is poorly documented, but preterm birth on its own is associated with cognitive impairment. Delivery should be postponed preferably until after a gestational age of 35 weeks.

Original languageEnglish
Title of host publicationRare and Uncommon Gynecological Cancers: A Clinical Guide
PublisherSpringer Berlin Heidelberg
Pages209-227
Number of pages19
ISBN (Print)9783642134913
DOIs
Publication statusPublished - 2011

Fingerprint

Consensus
Guidelines
Pregnancy
Neoplasms
Therapeutics
Drug Therapy
Premature Birth
Third Pregnancy Trimester
Second Pregnancy Trimester
Critical Care
Uterine Cervical Neoplasms
Ovarian Neoplasms
Gestational Age
Counseling
Pregnant Women
Fetus
Parents
Mothers
Prospective Studies
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Amant, F., Van Calsteren, K., Halaska, M. J., Beijnen, J., Lagae, L., Hanssens, M., ... Du Bois, A. (2011). Gynecologic cancers in pregnancy: Guidelines of an international consensus meeting. In Rare and Uncommon Gynecological Cancers: A Clinical Guide (pp. 209-227). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-13492-0_21

Gynecologic cancers in pregnancy : Guidelines of an international consensus meeting. / Amant, Frédéric; Van Calsteren, Kristel; Halaska, M. J.; Beijnen, J.; Lagae, L.; Hanssens, M.; Heyns, L.; Lannoo, L.; Ottevanger, P.; Van Den Bogaert, W.; Ungár, L.; Vergote, I.; Du Bois, A.

Rare and Uncommon Gynecological Cancers: A Clinical Guide. Springer Berlin Heidelberg, 2011. p. 209-227.

Research output: Chapter in Book/Report/Conference proceedingChapter

Amant, F, Van Calsteren, K, Halaska, MJ, Beijnen, J, Lagae, L, Hanssens, M, Heyns, L, Lannoo, L, Ottevanger, P, Van Den Bogaert, W, Ungár, L, Vergote, I & Du Bois, A 2011, Gynecologic cancers in pregnancy: Guidelines of an international consensus meeting. in Rare and Uncommon Gynecological Cancers: A Clinical Guide. Springer Berlin Heidelberg, pp. 209-227. https://doi.org/10.1007/978-3-642-13492-0_21
Amant F, Van Calsteren K, Halaska MJ, Beijnen J, Lagae L, Hanssens M et al. Gynecologic cancers in pregnancy: Guidelines of an international consensus meeting. In Rare and Uncommon Gynecological Cancers: A Clinical Guide. Springer Berlin Heidelberg. 2011. p. 209-227 https://doi.org/10.1007/978-3-642-13492-0_21
Amant, Frédéric ; Van Calsteren, Kristel ; Halaska, M. J. ; Beijnen, J. ; Lagae, L. ; Hanssens, M. ; Heyns, L. ; Lannoo, L. ; Ottevanger, P. ; Van Den Bogaert, W. ; Ungár, L. ; Vergote, I. ; Du Bois, A. / Gynecologic cancers in pregnancy : Guidelines of an international consensus meeting. Rare and Uncommon Gynecological Cancers: A Clinical Guide. Springer Berlin Heidelberg, 2011. pp. 209-227
@inbook{ab68a8ad702e45868b882b159eff6162,
title = "Gynecologic cancers in pregnancy: Guidelines of an international consensus meeting",
abstract = "Cancer in pregnancy presents a rare coincidence which demands intensive interdisciplinary care. Among this, gynecologic cancer is a special challenge because cancer or treatment may not only affect the pregnant women in general but involve the reproductive tract and fetus directly. Currently, there are no guidelines on how to deal with this special coincidence. An international consensus meeting on staging and treatment of gynecologic malignancies during pregnancy including systematic literature search, interpretation, and preparation followed by a physical meeting of all participants with intensive discussion. In the absence of large trials and randomized studies, recommendations were based on available literature data and personal experience, thus representing a low but best achievable level of evidence. Randomized trials and prospective studies on cancer treatment during pregnancy are lacking. Gynecologic cancer during pregnancy is a demanding problem and multidisciplinary expertise should be available. Counseling both parents on the maternal prognosis and fetal risk is needed. When there is a firm desire to continue the pregnancy, gynecologic cancer can be treated in selected cases. The staging and treatment should follow the standard approach as much as possible. Guidelines for safe pelvic surgery during pregnancy are presented. Mainly in cervical and ovarian cancer, chemotherapy and an alternative surgical approach need to be considered. Administration of chemotherapy during the second or third trimester may probably not increase the incidence of congenital malformations. Until now, the long-term outcome of children in utero exposed to oncological treatment modalities is poorly documented, but preterm birth on its own is associated with cognitive impairment. Delivery should be postponed preferably until after a gestational age of 35 weeks.",
author = "Fr{\'e}d{\'e}ric Amant and {Van Calsteren}, Kristel and Halaska, {M. J.} and J. Beijnen and L. Lagae and M. Hanssens and L. Heyns and L. Lannoo and P. Ottevanger and {Van Den Bogaert}, W. and L. Ung{\'a}r and I. Vergote and {Du Bois}, A.",
year = "2011",
doi = "10.1007/978-3-642-13492-0_21",
language = "English",
isbn = "9783642134913",
pages = "209--227",
booktitle = "Rare and Uncommon Gynecological Cancers: A Clinical Guide",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Gynecologic cancers in pregnancy

T2 - Guidelines of an international consensus meeting

AU - Amant, Frédéric

AU - Van Calsteren, Kristel

AU - Halaska, M. J.

AU - Beijnen, J.

AU - Lagae, L.

AU - Hanssens, M.

AU - Heyns, L.

AU - Lannoo, L.

AU - Ottevanger, P.

AU - Van Den Bogaert, W.

AU - Ungár, L.

AU - Vergote, I.

AU - Du Bois, A.

PY - 2011

Y1 - 2011

N2 - Cancer in pregnancy presents a rare coincidence which demands intensive interdisciplinary care. Among this, gynecologic cancer is a special challenge because cancer or treatment may not only affect the pregnant women in general but involve the reproductive tract and fetus directly. Currently, there are no guidelines on how to deal with this special coincidence. An international consensus meeting on staging and treatment of gynecologic malignancies during pregnancy including systematic literature search, interpretation, and preparation followed by a physical meeting of all participants with intensive discussion. In the absence of large trials and randomized studies, recommendations were based on available literature data and personal experience, thus representing a low but best achievable level of evidence. Randomized trials and prospective studies on cancer treatment during pregnancy are lacking. Gynecologic cancer during pregnancy is a demanding problem and multidisciplinary expertise should be available. Counseling both parents on the maternal prognosis and fetal risk is needed. When there is a firm desire to continue the pregnancy, gynecologic cancer can be treated in selected cases. The staging and treatment should follow the standard approach as much as possible. Guidelines for safe pelvic surgery during pregnancy are presented. Mainly in cervical and ovarian cancer, chemotherapy and an alternative surgical approach need to be considered. Administration of chemotherapy during the second or third trimester may probably not increase the incidence of congenital malformations. Until now, the long-term outcome of children in utero exposed to oncological treatment modalities is poorly documented, but preterm birth on its own is associated with cognitive impairment. Delivery should be postponed preferably until after a gestational age of 35 weeks.

AB - Cancer in pregnancy presents a rare coincidence which demands intensive interdisciplinary care. Among this, gynecologic cancer is a special challenge because cancer or treatment may not only affect the pregnant women in general but involve the reproductive tract and fetus directly. Currently, there are no guidelines on how to deal with this special coincidence. An international consensus meeting on staging and treatment of gynecologic malignancies during pregnancy including systematic literature search, interpretation, and preparation followed by a physical meeting of all participants with intensive discussion. In the absence of large trials and randomized studies, recommendations were based on available literature data and personal experience, thus representing a low but best achievable level of evidence. Randomized trials and prospective studies on cancer treatment during pregnancy are lacking. Gynecologic cancer during pregnancy is a demanding problem and multidisciplinary expertise should be available. Counseling both parents on the maternal prognosis and fetal risk is needed. When there is a firm desire to continue the pregnancy, gynecologic cancer can be treated in selected cases. The staging and treatment should follow the standard approach as much as possible. Guidelines for safe pelvic surgery during pregnancy are presented. Mainly in cervical and ovarian cancer, chemotherapy and an alternative surgical approach need to be considered. Administration of chemotherapy during the second or third trimester may probably not increase the incidence of congenital malformations. Until now, the long-term outcome of children in utero exposed to oncological treatment modalities is poorly documented, but preterm birth on its own is associated with cognitive impairment. Delivery should be postponed preferably until after a gestational age of 35 weeks.

UR - http://www.scopus.com/inward/record.url?scp=84889978127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889978127&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-13492-0_21

DO - 10.1007/978-3-642-13492-0_21

M3 - Chapter

AN - SCOPUS:84889978127

SN - 9783642134913

SP - 209

EP - 227

BT - Rare and Uncommon Gynecological Cancers: A Clinical Guide

PB - Springer Berlin Heidelberg

ER -